<DOC>
	<DOCNO>NCT01904175</DOCNO>
	<brief_summary>Allogeneic transplantation use treat many malignant non-malignant disease . The investigator others show less toxic preparative regimen ( reduce intensity 'mini ' transplant ) allow reliable allogeneic engraftment durable remission , significantly broaden population patient may offer therapy older infirmed . The field focus period post transplant approach immune recovery lead improve outcome . The primary objective registry catalogue data patient undergo standard care reduce intensity allogeneic transplantation .</brief_summary>
	<brief_title>Registry Study T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant</brief_title>
	<detailed_description>Subjects toxicity monitor report per Center International Blood Marrow Transplant Research ( CIBMTR ) program standard require law bone marrow transplant ( BMT ) report USA . Data collect physical exam , laboratory study , radiograph perform clinical purpose . The test procedure addition excess standard allogeneic transplant outside registry . Data donor also collect .</detailed_description>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Recipient Subjects â‰¥ 18 year age undergoing reduce intensity allogeneic transplant Subjects &lt; 18 year age Subjects undergoing nonmyeloablative ablative allogeneic transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Stem cell transplantation , non-myeloablative</keyword>
</DOC>